ArticleAmerican journal of cancer research2025

A novel tumor-associated macrophage risk signature predicts prognosis and immunotherapy response in lung adenocarcinoma.

Yingchuan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.